AIDS dementia

Of the more than 1.2 million people in the USA living with HIV it is estimated that more than 250,000 suffer from some form of learning and memory problems of the type often seen in patients treated with interferon for cancer or virus infection.

Scientists at Emory University School of Medicine have presented supporting evidence of interferon-alpha involvement in HIV Associated Neurocognitive Disorder (HAND) 1. In collaboration with Meiogen, we have tested this hypothesis in a HIV brain infected mouse model and demonstrated the ability of NormferonTM treatment to prevent HIV brain pathology 2 and reverse HIV associated learning difficulties 3.